Clinical Trials Logo

Clinical Trial Summary

This study evaluates the effect of amoxicillin in the treatment of lower airway infections in preschool children. Half of the patients will receive amoxicillin, while the other half will receive placebo.


Clinical Trial Description

The overall objective of the study is to determine if antibiotic therapy is beneficial in children with pneumonia who do not have a highly suspicious bacterial infection, such as in lobar pneumonia.

Secondary objective is to determine whether antibiotic use influence the microbial flora, including antibiotic resistance, in the airways in the short or medium long term.

The study is a phase IV double-blind, placebo-controlled, multicenter, nationwide, randomized superiority trial of amoxicillin versus placebo in children aged 1-5 years of age with a lower respiratory infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03446534
Study type Interventional
Source Oslo University Hospital
Contact Håvard O Skjerven, PhD
Phone +47 41020249
Email h.o.skjerven@medisin.uio.no
Status Recruiting
Phase Phase 4
Start date March 7, 2018
Completion date December 2020

See also
  Status Clinical Trial Phase
Recruiting NCT06016244 - Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial N/A
Recruiting NCT03391076 - The Clinical Value of FA in AHLRI Patients N/A
Completed NCT03694392 - Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years
Completed NCT01952470 - Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant. Phase 2
Recruiting NCT02929680 - Clinical Evaluation of FilmArray LRTI Panel N/A
Completed NCT02454114 - HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections N/A
Completed NCT01931254 - Assess a Diagnostic Tool to Distinguish Between Bacterial and Viral Infection N/A
Completed NCT00975780 - A Trial to Reduce Pneumonia in Nursing Home Residents Phase 3
Completed NCT00350987 - Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study N/A
Completed NCT00420966 - Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Recruiting NCT06210282 - The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice N/A
Recruiting NCT05110261 - Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China Phase 3
Recruiting NCT01985620 - The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. N/A
Recruiting NCT05374070 - Antiviral Activity of Oral Probiotics N/A
Recruiting NCT03808922 - Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study Phase 3
Not yet recruiting NCT03846401 - Bronchoscopy in Lower Respiratory Tract Infection in Respiratory Intensive Care Unit
Completed NCT01048073 - Non-influenza Etiologies of Acute Respiratory Illness in Southeast Asia N/A
Completed NCT00707941 - Oseltamivir Randomised Controlled Efficacy Trial Phase 3
Completed NCT04311320 - A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits N/A
Completed NCT01735084 - Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life Phase 4